Using selective withdrawal to encapsulate pancreatic islets for immunoisolation
ORAL
Abstract
We apply selective-withdrawal for encapsulating insulin-producing pancreatic islets within thin poly(ethylene glycol) (PEG) coats. Islets placed in an aqueous PEG solution are drawn into the selective-withdrawal spout which then breaks up, leaving the islets surrounded by a thin, 20$\mu $m, polymer coat. These coats, whose thickness is independent of the size of the encapsulated islet, are photo-crosslinked to form hydrogel capsules. We can apply multiple coats of varying chemical composition. These coats provide a semi-permeable membrane which allows the islets to respond to changes in glucose concentration by producing insulin in a manner similar to that of unencapsulated islets. Furthermore, the hydrogel capsules exclude large molecules the size of the smallest antibodies. Our results suggest that this microencapsulation technique may be useful for the transplantation of islets for treatment of Type I diabetes.
–
Authors
-
Jason Wyman
-
Seda Kizilel
-
Ryan Skarbek
-
Xiangyang Zhao
-
Matthew Connors
-
Shannon Dillmore
University of Chicago
-
William Murphy
University of Wisconsin
-
Milan Mrksich
-
Marc Garfinkel
-
Sidney Nagel
University of Chicago, James Franck Institute, University of Chicago, The James Franck Institute and Department of Physics, The University of Chicago